Skip to main content
← Back to companies
Syremis Therapeutics logo

Syremis Therapeutics

32+ employees

Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. The company’s neuropsychiatric pipeline is rooted in emerging and clinically validated mechanisms, including muscarinic M1/M4 agonism and next-generation NMDA antagonism.

Open Positions at Syremis Therapeutics (0 Jobs)

No open positions at the moment.

Browse All Jobs

Ready to start your space career at Syremis Therapeutics?

Shipping like we're funded. We're not. No affiliation.

Sequoia logo
Y Combinator logo
Founders Fund logo
a16z logo